Explore
Validate
LearnABIN2841761
antibody from antibodies-online
Targeting: FGFR2
BEK, CD332, CEK3, CFD1, ECT1, JWS, K-SAM, KGFR, TK14, TK25
Western blot
ImmunocytochemistryAntibody data
- Antibody Data
- Antigen structure
- References [9]
- Comments [0]
- Validations
- Western blot [2]
- Immunohistochemistry [2]
- Flow cytometry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN2841761 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Fibroblast Growth Factor Receptor 2 (FGFR2) (AA 7-37), (N-Term) antibody
- Antibody type
- Polyclonal
- Description
- This antibody is purified through a protein A column, followed by peptide affinity purification.
- Reactivity
- Human, Mouse, Rat, Simian
- Host
- Rabbit
- Epitope
- AA 7-37, N-Term
- Antibody clone number
- RB01567
- Vial size
- 80 μL
- Storage
- Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Submitted references miR-223 Regulates Adipogenic and Osteogenic Differentiation of Mesenchymal Stem Cells Through a C/EBPs/miR-223/FGFR2 Regulatory Feedback Loop.
Induction of stem cell gene expression in adult human fibroblasts without transgenes.
E2F-1-deficient NOD/SCID mice developed showing decreased saliva production.
A tissue-engineered model of fetal distal lung tissue.
Conditional activation of fibroblast growth factor receptor (FGFR) 1, but not FGFR2, in prostate cancer cells leads to increased osteopontin induction, extracellular signal-regulated kinase activation, and in vivo proliferation.
FGFR2 and WDR11 are neighboring oncogene and tumor suppressor gene on human chromosome 10q26.
Recombination cluster around FGFR2-WDR11-HTPAPL locus on human chromosome 10q26.
P63 alpha mutations lead to aberrant splicing of keratinocyte growth factor receptor in the Hay-Wells syndrome.
Evidence for selective advantage of pathogenic FGFR2 mutations in the male germ line.
Guan X, Gao Y, Zhou J, Wang J, Zheng F, Guo F, Chang A, Li X, Wang B
Stem cells (Dayton, Ohio) 2015 May;33(5):1589-600
Stem cells (Dayton, Ohio) 2015 May;33(5):1589-600
Induction of stem cell gene expression in adult human fibroblasts without transgenes.
Page RL, Ambady S, Holmes WF, Vilner L, Kole D, Kashpur O, Huntress V, Vojtic I, Whitton H, Dominko T
Cloning and stem cells 2009 Sep;11(3):417-26
Cloning and stem cells 2009 Sep;11(3):417-26
E2F-1-deficient NOD/SCID mice developed showing decreased saliva production.
Matsui-Inohara H, Uematsu H, Narita T, Satoh K, Yonezawa H, Kuroda K, Ito T, Yoneda S, Kawarai T, Sugiya H, Watanabe H, Senpuku H
Experimental biology and medicine (Maywood, N.J.) 2009 Dec;234(12):1525-36
Experimental biology and medicine (Maywood, N.J.) 2009 Dec;234(12):1525-36
A tissue-engineered model of fetal distal lung tissue.
Mondrinos MJ, Koutzaki S, Lelkes PI, Finck CM
American journal of physiology. Lung cellular and molecular physiology 2007 Sep;293(3):L639-50
American journal of physiology. Lung cellular and molecular physiology 2007 Sep;293(3):L639-50
Conditional activation of fibroblast growth factor receptor (FGFR) 1, but not FGFR2, in prostate cancer cells leads to increased osteopontin induction, extracellular signal-regulated kinase activation, and in vivo proliferation.
Freeman KW, Gangula RD, Welm BE, Ozen M, Foster BA, Rosen JM, Ittmann M, Greenberg NM, Spencer DM
Cancer research 2003 Oct 1;63(19):6237-43
Cancer research 2003 Oct 1;63(19):6237-43
FGFR2 and WDR11 are neighboring oncogene and tumor suppressor gene on human chromosome 10q26.
Katoh M, Katoh M
International journal of oncology 2003 May;22(5):1155-9
International journal of oncology 2003 May;22(5):1155-9
Recombination cluster around FGFR2-WDR11-HTPAPL locus on human chromosome 10q26.
Katoh M, Katoh M
International journal of molecular medicine 2003 May;11(5):579-83
International journal of molecular medicine 2003 May;11(5):579-83
P63 alpha mutations lead to aberrant splicing of keratinocyte growth factor receptor in the Hay-Wells syndrome.
Fomenkov A, Huang YP, Topaloglu O, Brechman A, Osada M, Fomenkova T, Yuriditsky E, Trink B, Sidransky D, Ratovitski E
The Journal of biological chemistry 2003 Jun 27;278(26):23906-14
The Journal of biological chemistry 2003 Jun 27;278(26):23906-14
Evidence for selective advantage of pathogenic FGFR2 mutations in the male germ line.
Goriely A, McVean GA, Röjmyr M, Ingemarsson B, Wilkie AO
Science (New York, N.Y.) 2003 Aug 1;301(5633):643-6
Science (New York, N.Y.) 2003 Aug 1;301(5633):643-6
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- FACS
